A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis

QJM: An International Journal of Medicine

Volumn 105, Issue 10, 2012, Pages 1011-1016

  Pallin, M ^a   O'Sullivan, C ^a   Dodd, J D ^a   McCreery, K ^b   Brett, F ^c   Farrell, M ^c   O'Brien, D ^c   Hall, W W ^a   Tubridy, N J ^a   Keane, M P ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b Blackrock Clinic Ireland   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; PREDNISOLONE;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIMETRY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SARCOIDOSIS; VISUAL FIELD DEFECT;

EID: 84867132467     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr154     Document Type: Article

References (39)

1. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, et al. Treatment of progressive multifocal leucoencephalopathy associated with natalizumab. NEJM 2009; 361:1075-80.
2. Linda H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, et al. Progressive multifocal leucoencephalopathy after natalizumab monotherapy. NEJM 2009; 361:1081-87.
3. Clifford DB, De Luca A, Simpson DB, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010; 9:438-46.
4. Aksamit Jr AJ. Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech 1995; 32:302-11.
5. Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 2006; 12:293-8.
6. Eng PM, Turnbull BR, Cook SF, Davidson JE, Kurth T, Seeger JD. Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 2006; 67:884-886.
7. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008; 26:833-54.
8. Major EO. Reemergence of PML in natalizumab-treated patients-new cases, same concerns. NEJM 2009; 361: 1041-3.
9. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009; 113:4834-40.
10. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neuro Virol 2001; 7:386-90.
11. Focosi D, Kast RE, Maggi F, Lauria G, Ceccherini-Nelli L, Petrini M. 5-HT2a inhibitors for progressive multifocal leckoencephalopathy: old drugs for an old disease. JID 2008; 197:328.
12. Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A. Progressive multifocal leukoencephalopathy in a patient with sarcoidosis-successful treatment with cidofovir and mirtazepine. Rheumatology 2007; 46:888-90.
13. Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993; 33:407-11.
14. Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Parsquier RA, Fux CA, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009; 48:1459-66.
15. Yagi T, Hattori H, Ohira M, Nakamichi K, Takayama-Ito M, Saijo M, et al. Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. Clin Neurol Neurosurg 2010; 112:153-6.
16. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 2009; 53:1840-9.
17. Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy, [www.clinicaltrials. gov] accessed 14 April 2011 (ClinicalTrials.gov Identifier: NCT00746941).
18. Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 2009; 199: 77-83.
19. Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009; 72:1458-64.
20. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2:299-313.
21. Völker HU, Kraft K, Arnold E, Steinhoff S, Kollos G, Sommer S. Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis. Clin Neurol Neurosurg 2007; 109:624-30.
22. Mackowiak-Cordoliani MA, De Seze J, Stojkovic T, Ferriby D, Ingrand D, Vermersch P. Sarcoidosis and progressive multifocal leukoencephalopathy. Rev Neurol 2001; 157:547-50.
23. Rosenbloom MA, Uphoff DF. The association of progressive multifocal leukoencephalopathy and sarcoidosis. Chest 1983; 83:572-5.
24. de Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Progressive multifocal leucoencephalopathy as first manifestation of sarcoidosis. Clinical Neurology and Neurosurgery 2008; 110:186-9.
25. Girard N, Cottin V, Hot A, Etienne-Mastroianni B, Chidiac C, Cordier JF. Opportunistic infections and sarcoidosis. Rev Mal Respir 2004; 21(6 part 1):1083-90.
26. Dhote R, Abad S, Valeyre D. The infectious complications of sarcoidosis. Presse Med 2009; 38:317-23.
27. Gormand F, Ecochard D, Aloui R, Perrin-Fayolle M, Pacheco Y. T-lymphocytes disorders in pulmonary sarcoidosis. Rev Mal Respir 1990; 7:187-94.
28. Davies BH, Williams JD, Smith MD, Jones-Williams W, Jones K. Peripheral blood lymphocytes in sarcoidosis. Pathol Res Pract 1982; 175:97-109.
29. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203:359-70.
30. Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 2009; 80:297-304.
31. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosisdiagnosis and management. Q J Med 1999; 92:103-17.
32. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. Q J Med 2009; 102:449-60.
33. von Giesen HJ, Neuen-Jacob E, Dorries K, Jablonowski H, Roick H, Arendt G. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 1997; 147:63-72.
34. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993; 187:233-40.
35. Fels C, Riegel A, Javaheripour-Otto K, Obenauer S. Neurosarcoidosis Findings in MRI. J Clin Imaging 2004; 28:166-9.
36. Pickuth D, Spielmann RP, Heywang-Kobrunner SH. Role of radiology in the diagnosis of neurosarcoidosis. Eur Radiol 2000; 10:941-4.
37. Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. Am J Neuroradiol 1999; 20:655-69.
38. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-8.
39. Thurnher MM, Thurnher SA, Muhlbauer B, Hainfellner JA, Steuer A, Fleischmann D, et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 1997; 39:611-8. 1016.